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Sir 
 
India is undergoing a rapid epidemiological 
transition with increased urbanization and socio- 
economic development which has resulted in a 
dramatic change in lifestyle consisting of physical 
inactivity, diet rich in fat, sugar and salt coupled 
with a high level of mental stress. This has led to 
increased incidence of lifestyle diseases like 
hypertension, type 2 Diabetes Mellitus (DM), 
dyslipidemias, obesity and ischemic heart diseases. 
In India, 41 million people are having type 2 DM 
and by 2025 the number is expected to be 68 
million. As of today, every fifth diabetic person in 
the world is Indian. Therefore India is called the 
diabetic capital of the world. It is also projected 
that out of these diabetics, 20 millions are obese .
1 
According to WHO, pre-obesity and obesity lead to 
serious health consequences. It also increases 
insulin resistance and fasting hyperglycemia along 
with altered lipid profile like increased triglycerides 
and decreased high density lipoproteins (HDL). As 
a result, risk for type 2 DM, metabolic syndrome, 
hypertension and stroke increases linearly with 
increase in body mass index (BMI). 
The connection between obesity and type 2 DM is 
so strong that attempting to treat diabetes without 
managing any coexisting obesity is almost futile. 
Therefore many experts consider obesity and type 2 
DM to be different ends of the same spectrum, 
together called ‘diabesity’. For this reason obesity 
can be considered a pre-diabetic condition. 
Insulin resistance is a characteristic feature of type 
2 DM and central obesity plays a key role in its 
development. Central fat depots are viewed as 
endocrine tissues that secrete various chemicals 
collectively known as adipokines i.e. leptin, 
resistin, tumor necrotic factor α, adiponectine, 
ghrelin, angiotensinogen, plasminogen activator 
inhibitor & many others. Some of these chemicals 
like resistin & TNF α promote insulin resistance 
while others like adiponectin & leptin decrease 
insulin resistance.
2 
Experimental evidence supports the above 
observations. When glucose transporters were 
selectively knocked out in adipose tissue of 
animals, glucose transport in muscle in vitro was 
normal but when those animals were tested in vivo, 
there was an associated decrease in glucose 
transport in muscle. This could probably be due to 
release of chemical signals from the adipose tissue 
which acts on the glucose transporters in the 
muscle
3.  This indicates that adipokines from fat 
depots modulate insulin secretion and insulin action 
& may contribute to insulin resistance. A variety of 
knockouts of intracellular second messenger 
systems have been reported to increase insulin 
resistance. 
This underscores the need for mass awareness and 
screening programmes to detect diabetes and 
obesity at an early stage & health education of 
public regarding lifestyle modifications. 
The American Diabetes Association (ADA) 
recommends screening of all individuals who are 
more than 45 years of age every 3 years and 
screening of  individuals at an earlier age if they are 
overweight or obese and have one additional risk 
factor for diabetes like family history of diabetes 
(i.e. parent or sibling with type 2 DM) or  habitual 
physical inactivity,  previously identified impaired 
fasting glucose  or impaired glucose tolerance  or 
history of  delivery of a baby having birth weight 
more than 4 kg or hypertension (blood pressure 
≥140/90 mmHg) or HDL cholesterol level ≤35 
mg/dL and/or triglyceride  level ≥250 mg/dl or   
polycystic ovary disease or acanthosis nigricans  or 
history of vascular disease .
4 
In India, Mohan et al have developed a simple 
screening tool namely Indian Diabetes Risk Score 
(IDRS)
5 to determine the risk of developing type 2 
DM for general population. Measuring this score is 
a simple and inexpensive method, which only 
requires answers to four simple questions and a 
waist measurement. (Table 1) Using IDRS, 
individuals who are at high risk of developing 
diabetes can be detected. Then, for subjects with 
IDRS score ≥60, Random Capillary Blood Glucose 
(RCBG) can be done to diagnose diabetes mellitus.  Kachewar et al / Macrodystrophia Lipomatosa: a rare presentation 
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RCBG has an advantage, that it can be undertaken 
at any time of the day and does not require a 
venipuncture.   People having  RCBG ≥140 mg/dl 
are most likely to have frank diabetes mellitus 
while those having RCBG above 113 mg/dl are 
likely to have pre-diabetic status and likely to have 
impaired fasting glucose (IFG). These subjects can 
be investigated further by doing fasting & 
postprandial blood glucose, glucose tolerance test 
(GTT) & glycosylated hemoglobin to confirm their 
hyperglycemic status. Thus IDRS can be an 
economical and reliable measure to screen general 
population for risk of developing type 2 DM 
 
Table 1: Indian Diabetes Risk Score (IDRS)
5 
 
Particulars Score 
Age (years) 
•  <35 
•  35-49 
•  ≥50 
 
0 
20 
30 
Abdominal obesity 
•  Waist <80cm (F), <90cm (M) 
•  Waist ≥80-89cm (F), ≥90-99cm (M) 
•  Waist ≥90cm (F), ≥100cm (M) 
 
0 
10 
20 
Physical activity 
•  Exercise (regular) + strenuous work 
•  Exercise (regular) or strenuous work 
•  No exercise and sedentary work 
 
0 
20 
30 
Family history 
•  No family history 
•  Either parent 
•  Both parents 
 
0 
10 
20 
Minimum score  0 
Maximum score  100 
Interpretation of Score 
High risk ≥60; Moderate risk 30-59; High risk <30 
Once a person is warned about his dysglycemic 
status with the help of these tests, he can be 
motivated for lifestyle modifications to delay the 
onset of diabetes especially by reducing body 
weight. One hopes that with these measures, 
disease burden can be reduced to a great extent. 
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